[ad_1]
the UK also gives the green light to the administration of the anti-Covid vaccine developed by Oxford – AstraZeneca. The authorization came from the Regulatory Agency for Medicines and Health Products Regulatory Agency for Medicines and Health Products (Mhra). “Now the NHS will begin to implement i preparations for the launch of the vaccine from the University of Oxford / AstraZeneca ”, reads a note from the British government. This is the second vaccine licensed in the UK after that. Pfizer / BioNTech which had already gotten the green light from the MHRA on December 2: last week the first British received their doses, according to the vaccination plan. “With two authorized vaccines, underlines the government’s note, we will be able to vaccinate a greater number of people who are at high risk.” protect them from disease and reduce mortality and hospitalizations“.
The news of the MHRA authorization comes in the wake of the cold shower announced by the deputy executive director of theMother (the European Medicines Agency), Noel wathion, which he defined “unlikely” green light for AstraZeneca vaccine a January for the European Union. The reason? “They are needed Other data on the quality of the drug. “” We do not know what data AstraZeneca has presented to the British authorities, “Wathion explained yesterday. Already at the beginning of December there had been controversy between the United Kingdom and the EU, after the green light arrived from the MHRA to Pfizer through an approval procedure. emergency, while the EMA uses an authorization procedure conditioning, which requires further verification.
However, the UK authorization for AstraZeneca had been Announced in recent days: London aims to start distribution now before January 4. In an interview with sunday time, the CEO of AstraZeneca, Pascal Soriot, spoke of a “winning formula” against Covid. This is also why we were surprised by the words spoken yesterday by Wathion. However, given the delay in granting the go-ahead by the EMA methodological errors committed in the first experimentation from AstraZeneca and Oxford vaccine candidate. This is what emerges from the analysis of new protocol related to the Phase 3 study.
Support ilfattoquotidiano.it: I never eat right now
we need you.
In these weeks of pandemic, journalists, if we do our job conscientiously, we do a public service. Also for this reason, every day here at ilfattoquotidiano.it we are proud to offer hundreds of new content for free to all citizens: news, exclusive insights, expert interviews, surveys, videos and much more. All this work, however, comes at great financial cost. Advertising, at a time when the economy is stagnant, offers limited income. Not in line with the access boom. That is why I ask those who read these lines to support us. Give us a minimum contribution, equal to the price of a cappuccino per week, which is essential for our work.
Become a support user by clicking here.
Thank you
Peter gomez
THANKS FOR READING NOW XX ITEMS THIS MONTH.
But now we are the ones who need you. Because our work has a cost. We are proud to be able to offer hundreds of new content to all citizens for free every day. But advertising, at a time when the economy is stagnant, offers limited revenue. Not in line with the boom in access to ilfattoquotidiano.it. That is why I ask you to support us, with a minimum contribution, equal to the price of one cappuccino per week. A small but fundamental sum for our work. Give us a hand!
Become a support user!
With gratitude
Peter gomez
Support now
Previous article
Vaccine, already at the beginning of December Berlin was negotiating with Biontech and other companies to obtain more doses. Internal pressures for acceleration
Next article
Coronavirus, record of deaths in Germany: for the first time more than a thousand deaths in 24 hours
[ad_2]
